What is TELA Bio Inc Annual Revenue?

TELA Bio Inc Annual Revenue rose 18.56%, in the last year to $69.3 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

What is TELA Bio Inc Annual Net Profit?

TELA Bio Inc Annual Net Profit rose 18.91% in the last year to $37.84 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

What is TELA Bio Inc Price to Earning Ratio?

TELA Bio Inc Price to Earning Ratio is -1, which is negative.

What is TELA Bio Inc Stock Price?

TELA Bio Inc Stock Price fell 79.79% and underperformed its sector by 85.22% in the past year.

What is TELA Bio Inc Quarterly Revenue?

TELA Bio Inc Quarterly Revenue rose 3.83% YoY to $17.65 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

What is TELA Bio Inc Quarterly Net profit?

TELA Bio Inc Quarterly Net profit rose 28.56% YoY to $9.21 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

What is TELA Bio Inc Debt to Equity Ratio?

TELA Bio Inc Debt to Equity Ratio of 1.46 is higher than 1. This implies that company assets are financed through debt.

What is TELA Bio Inc Return on Equity(ROE)?

TELA Bio Inc Return on Equity(ROE) for the last financial year was -159.87%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is TELA Bio Inc Mutual Fund Holding?

TELA Bio Inc Mutual Fund Holding decreased by 1.75% in the last quarter to 11.27.

What is TELA Bio Inc Promoter Share Holding?

TELA Bio Inc Promoter Share Holding increased by 2.4% in the most recent quarter to 10.23%.

What is TELA Bio Inc Interest Coverage Ratio?

TELA Bio Inc Interest Coverage Ratio is -6.18, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is TELA Bio Inc Institutional Holding?

TELA Bio Inc Institutional Holding remained the same in the last quarter at 69.04%.

How is the TELA Bio Inc today?

The TELA Bio Inc today is trading in the down by 0.00% at 0.96.

How has TELA Bio Inc performed historically?

The TELA Bio Inc is currently trading down 0.00% on an intraday basis in the past week the index fell -2.04%. The index has been down -64.31% in the past quarter and fell -79.79% in the past year. You can view this in the overview section.

TELA Bio Inc XNAS: TELA

TELA Bio Inc Live Share Price Today, Share Analysis and Chart

Name: TELA Bio Inc: Is Infosys Ltd. worth buying?
Item: TELA Bio Inc
Rating: 1.11050
Author: Trendlyne DVM scores

Download real time

0.96 0.00 (0.00%)

85.23% Fall from 52W High

76,557 XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

TELA Bio Inc Key Metrics

My Metrics

Select

Market Capitalization Below industry Median Unavailable in chosen country	38
PE TTM Negative PE TTM Unavailable in chosen country	-1
PEG TTM Negative PEG TTM Unavailable in chosen country	-0.1
Price to Book Below industry Median Unavailable in chosen country	1.3
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	69
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	3.8
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	18.6
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	28.6
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	18.9
Operating Profit Margin Qtr % Negative Operating Profit Margin Qtr % Unavailable in chosen country	-47.3
Operating Profit Margin TTM % Negative Operating Profit Margin TTM % Unavailable in chosen country	-60.2
Piotroski Score Below industry Median Unavailable in chosen country	3
Rel Perf vs Sector quarter% Unavailable in chosen country	-57.1
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-159.9
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-46

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

25.5 / 100

Technically Bearish

18.9 / 100

1Yr Price target upside is 504%

5 analysts

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

TELA Bio Inc Stock Price Analysis

Week Price Range -2.0% 1 Week return Unavailable in chosen country	1 (LTP) 0.91.1 LowHigh
Month Price Range -59.0% 1 Month return Unavailable in chosen country	1 (LTP) 0.91.9 LowHigh
52 Week Price Range -79.8% 1 Year return Unavailable in chosen country	1 (LTP) 0.96.5 LowHigh

View full Share Price History

TELA Bio Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Miss

TELA Bio Inc's Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

-1.3

Avg. Estimate

-0.7

Low Estimate

-0.9

High Estimate

-0.6

Current EPS

Avg. Estimate

Consensus Recommendation

5 ANALYST Recommendations

BUY

The consensus recommendation from 5 analysts for TELA Bio Inc is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

TELA Bio Inc Stock Analysis

TELA Bio Inc stock analysis with key metrics, changes, and trends.

TELA Bio Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$69.3 M	18.56%	positive	Annual Revenue rose 18.56%, in the last year to $69.3 M. Its sector's average revenue growth for the last fiscal year was 8.57%.
Annual Net Profit	$37.84 M	18.91%	positive	Annual Net Profit rose 18.91% in the last year to $37.84 M. Its sector's average net profit growth for the last fiscal year was 4.36%.
Price to Earning Ratio	-1	-	negative	Price to Earning Ratio is -1, which is negative.
Stock Price	$0.96	-79.79%	negative	Stock Price fell 79.79% and underperformed its sector by 85.22% in the past year.
Quarterly Revenue	$17.65 M	3.83%	positive	Quarterly Revenue rose 3.83% YoY to $17.65 M. Its sector's average revenue growth YoY for the quarter was 8.5%.
Quarterly Net profit	$9.21 M	28.56%	positive	Quarterly Net profit rose 28.56% YoY to $9.21 M. Its sector's average net profit growth YoY for the quarter was 32.89%.
Debt to Equity Ratio	1.46	-	negative	Debt to Equity Ratio of 1.46 is higher than 1. This implies that company assets are financed through debt.
Return on Equity(ROE)	-159.87 %	-159.87%	negative	Return on Equity(ROE) for the last financial year was -159.87%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	11.27 %	-1.75%	negative	Mutual Fund Holding decreased by 1.75% in the last quarter to 11.27.
Promoter Share Holding	10.23 %	2.4%	positive	Promoter Share Holding increased by 2.4% in the most recent quarter to 10.23%.
Interest Coverage Ratio	-6.18	-	negative	Interest Coverage Ratio is -6.18, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	69.04 %	0%	neutral	Institutional Holding remained the same in the last quarter at 69.04%.

VIEW LESS

Loading data..

TELA Bio Inc - Company Profile

What does TELA Bio Inc do?

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

88.4 K

2024

Gross Remuneration

Year

TELA Bio Inc Live Share Price Today, Share Analysis and Chart

85.23% Fall from 52W High

TELA Bio Inc Key Metrics

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

TELA Bio Inc Stock Price Analysis

Week Price Range

Month Price Range

52 Week Price Range

TELA Bio Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

TELA Bio Inc's Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

Consensus Recommendation

The consensus recommendation from 5 analysts for TELA Bio Inc is BUY

TELA Bio Inc Stock Analysis

TELA Bio Inc stock analysis with key metrics, changes, and trends.

Annual Revenue rose 18.56%, in the last year to $69.3 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit rose 18.91% in the last year to $37.84 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio is -1, which is negative.

Stock Price fell 79.79% and underperformed its sector by 85.22% in the past year.

Quarterly Revenue rose 3.83% YoY to $17.65 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit rose 28.56% YoY to $9.21 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

Debt to Equity Ratio of 1.46 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE) for the last financial year was -159.87%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 1.75% in the last quarter to 11.27.

Promoter Share Holding increased by 2.4% in the most recent quarter to 10.23%.

Interest Coverage Ratio is -6.18, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding remained the same in the last quarter at 69.04%.

TELA Bio Inc - Company Profile

What does TELA Bio Inc do?

TELA Bio Inc Management structure

Mr. Anthony Koblish

Director, President and Chief Executive Officer

Mr. Roberto Cuca

Chief Operating Officer and Chief Financial Officer

Mr. Paul Talmo

Chief Technology Officer

Ms. Megan Smeykal

Chief Accounting Officer and Corporate Controller

Mr. Peter C. Murphy

Chief Commercial Officer

Mr. Gregory A. Firestone

Chief Commercial Officer

TELA Bio Inc Board of directors

Mr. Doug Evans

Chairman of the Board

Ms. Lisa N. Colleran

Independent Director

Ms. Federica O'Brien

Independent Director

Mr. Vincent J. Burgess

Independent Director

Mr. Kurt Azarbarzin

Independent Director

Mr. Jeffrey Blizard

Independent Director

TELA Bio Inc FAQ

How is TELA Bio Inc today?

TELA Bio Inc today is trading in the red, and is down by 0.00% at 0.96.

How has TELA Bio Inc performed historically?

TELA Bio Inc is currently trading down 0.00% on an intraday basis. In the past week the stock fell -2.04%. stock has been down -64.31% in the past quarter and fell -79.79% in the past year. You can view this in the overview section.